CIRRUS LOGIC, INC. Insider Trading Activity
Cirrus Logic EVP and General Counsel Scott Thomas reported an option exercise and share sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cirrus Logic EVP and General Counsel Scott Thomas reported an option exercise and share sale. On 02/13/2026 he exercised an Incentive Stock Option for 3,239 shares of common stock at an exercise price of $54.65 per share and received the shares.
That same day, he sold 3,239 shares of common stock in an open-market transaction at a weighted average price of $141.63 per share, with individual sale prices ranging from $140.38 to $142.93. After these transactions, he directly owned 30,393 shares of Cirrus Logic common stock. The transactions were made under a Rule 10b5-1 trading plan adopted on November 14, 2025.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Incentive Stock Option (right to buy) | 3,239 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,239 | $54.65 | $177K |
| Sale | Common Stock | 3,239 | $141.63 | $459K |
Footnotes (3)
- F1. This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2025.
- F2. The price reported in Table I - Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.38 to $142.93. The reporting person will provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to any security holder of Cirrus Logic, Inc. or the staff of the SEC upon request.
- F3. Only vested shares can be exercised under this option. 25% of the shares vested and became exercisable on November 2, 2017; the remaining shares vested monthly over the following 36 months so that the option was fully vested and exercisable on November 2, 2020.
AI-generated analysis. How Rhea-AI works. Not financial advice.